BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15681458)

  • 1. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
    Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
    J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.
    Ludwig H; Suezer Y; Waibler Z; Kalinke U; Schnierle BS; Sutter G
    J Gen Virol; 2006 May; 87(Pt 5):1145-1155. PubMed ID: 16603515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.
    Zhang P; Jacobs BL; Samuel CE
    J Virol; 2008 Jan; 82(2):840-8. PubMed ID: 17959656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
    Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.
    Sperling KM; Schwantes A; Staib C; Schnierle BS; Sutter G
    J Virol; 2009 Jun; 83(12):6029-38. PubMed ID: 19357172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.
    Sliva K; Martin J; von Rhein C; Herrmann T; Weyrich A; Toda M; Schnierle BS
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
    Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
    J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range.
    Langland JO; Jacobs BL
    Virology; 2002 Jul; 299(1):133-41. PubMed ID: 12167348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.
    Guerra S; López-Fernández LA; Conde R; Pascual-Montano A; Harshman K; Esteban M
    J Virol; 2004 Jun; 78(11):5820-34. PubMed ID: 15140980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
    Xiang Y; Condit RC; Vijaysri S; Jacobs B; Williams BR; Silverman RH
    J Virol; 2002 May; 76(10):5251-9. PubMed ID: 11967338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
    Wolferstätter M; Schweneker M; Späth M; Lukassen S; Klingenberg M; Brinkmann K; Wielert U; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2014 Dec; 88(24):14396-411. PubMed ID: 25297997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.
    Shors T; Kibler KV; Perkins KB; Seidler-Wulff R; Banaszak MP; Jacobs BL
    Virology; 1997 Dec; 239(2):269-76. PubMed ID: 9434718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
    Arsenio J; Deschambault Y; Cao J
    Virology; 2008 Jul; 377(1):124-32. PubMed ID: 18502465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
    Deng L; Dai P; Ding W; Granstein RD; Shuman S
    J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.
    Langland JO; Kash JC; Carter V; Thomas MJ; Katze MG; Jacobs BL
    J Virol; 2006 Oct; 80(20):10083-95. PubMed ID: 17005686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
    Shisler JL; Jin XL
    J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-range restriction of vaccinia virus E3L-specific deletion mutants.
    Beattie E; Kauffman EB; Martinez H; Perkus ME; Jacobs BL; Paoletti E; Tartaglia J
    Virus Genes; 1996; 12(1):89-94. PubMed ID: 8879125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.